Strikingly, our results showed that the absence of SOS1, but not SOS2, in the lungs of the recipient, injected mice dramatically reduced the tumor burden of KPB6-dependent lung tumors as compared to their SOS1/2WT/KRASWT WT counterparts (Fig. 5b, c). This evidence concerns the gene SOS2 and neoplasm.